Oral vaccine | Target ages at which diminished immunogenicity or protection was observed | Geographic locations where observed | References |
---|---|---|---|
Sabin polio vaccine strains | Infants, toddlers, preschool children, school-age children | India, sub-Saharan Africa | |
RIT 4237 rotavirus | Infants | Gambia | [36] |
Rotashield rotavirus vaccine (104 plaque forming unit dosage) | Infants | Brazil and Peru | |
Rotarix attenuated rotavirus | Infants | Malawi, South Africa, Bangladesh | [38] |
Rotateq pentavalent attenuated rotavirus | Infants | Ghana, Kenya, Mali | [39] |
MMU18006 (monovalent Rhesus rotavirus strain) | Infants | Pakistan | [40] |
CVD 103-HgR live cholera strain | 24-59 months; 5-9 years; adults | Indonesia, Thailand, Peru, Ecuador | |
Dukoral non-living cholera vaccine (killed V. cholerae O1 plus B subunit) | 1-12 years | Nicaragua | [45] |
SC602 attenuated Shigella flexneri strain | Toddlers and school age children | Bangladesh |